Skip to main content

Table 3 Response criteria influenced by BMI identified through multivariate analysis: a higher BMI is independently associated with a nonresponse of ankylosing spondyloarthritis to infliximab at month 6a

From: Body mass index influences the response to infliximab in ankylosing spondylitis

Response criteria Pvalue OR (95% CI]a
BASDAI50 0.0003 0.87 (0.81-0.94)
VAS50 < 0.0001 0.87 (0.80-0.93)
CRP50 0.0279 0.93 (0.88-0.99)
NSAID50 0.0077 0.91 (0.85-0.97)
  1. aAdjusted on significant factors in univariate analysis (P < 0.20). BASDAI, Bath ankylosing spondylitis disease activity index; CRP, C-reactive protein; NSAIDs, nonsteroidal antiinflammatory drugs; VAS, visual analogue scale.